Dr. Reddy's Laboratories (DRREDDY) — Financial Results

Dr. Reddy's Laboratories received a letter from the U.S. Securities and Exchange Commission on February 23, 2026, concluding its investigation into allegations of improper payments to healthcare professionals in Ukraine and other countries related to potential Foreign Corrupt Practices Act violations. The SEC stated it does not intend to recommend enforcement action against the company at this time. The company has fully cooperated with U.S. and Indian authorities throughout the investigation.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this financial results affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 24 February 2026?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 24 February 2026

IRFC Indian Railway Finance Corporation Limited Offer Document IRFC Indian Railway Finance Corporation Limited Offer Document AXISBANK Axis Bank Limited Corporate Action ICICIPRULI ICICI Prudential Life Insurance Company Limited Board Meeting INDUSINDBK IndusInd Bank Limited Voting Results INDUSINDBK IndusInd Bank Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.